OROCAL Side Effects

6341448-8 | Erythrodermic Psoriasis
on Aug 27, 2009 Male patient from FRANCE , 77 years of age, was treated with Orocal (View Usage). Patient experienced the following unwanted or unexpected effects: erythrodermic psoriasis. Orocal dosage: Unk. During the same period patient was treated with EQUANIL (Unk) (View Equanil Review and Equanil Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), LEVOTHYROXINE SODIUM (Unk) (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), XATRAL (View Xatral Review and Xatral Label ). Patient was hospitalized.

6080831-5 | Erythrodermic Psoriasis
Patient was taking Orocal (View Usage). Patient had the following side effects: erythrodermic psoriasis on Feb 06, 2009 from FRANCE Additional patient health information: Male patient , 77 years of age, . Orocal dosage: Unk. During the same period patient was treated with EQUANIL (Unk) (View Equanil Review and Equanil Label ), ATARAX (Unk) (View Atarax Review and Atarax Label ), LEVOTHYROX (Unk) (View Levothyrox Review and Levothyrox Label ), XATRAL (View Xatral Review and Xatral Label ). Patient was hospitalized.

5806397-X | Fall, Rhabdomyolysis
Adverse event was reported on Jun 27, 2008 by a Female patient taking Orocal (View Usage) (Dosage: ) . Location: FRANCE , weighting 147.7 lb, After Orocal was administered, patient had the following side effects: fall (What is fall?), rhabdomyolysis. During the same period patient was treated with CHRONADALATE (View Chronadalate Review and Chronadalate Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), ATHYMIL (View Athymil Review and Athymil Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), LASIX (View Lasix Review and Lasix Label ). Patient was hospitalized.

5306228-0 | Anaemia, Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Potassium Decreased, Carbon Dioxide Decreased, Confusional State, Creatinine Renal Clearance Decreased, Dehydration
on Apr 18, 2007 Female patient from FRANCE , 80 years of age, weighting 99.21 lb, was diagnosed with essential hypertension and was treated with Orocal (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, confusional state, creatinine renal clearance decreased, dehydration. Orocal dosage: 1.25 G, Qd. During the same period patient was treated with KARDEGIC (1 Df, Qd) (View Kardegic Review and Kardegic Label ), IRBESARTAN (1 Df, Qd) (View Irbesartan Review and Irbesartan Label ), STILNOX /FRA/ (10 Mg, Unk) (View Stilnox /fra/ Review and Stilnox /fra/ Label ), VICTAN (1 Mg, Qd) (View Victan Review and Victan Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.


5305296-X | Anaemia, Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Potassium Decreased, Carbon Dioxide Decreased, Confusional State, Creatinine Renal Clearance Decreased, Dehydration
on Apr 18, 2007 Female patient from FRANCE , 80 years of age, weighting 99.21 lb, was diagnosed with essential hypertension and was treated with Orocal (View Usage). Patient had the following side effects: anaemia, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, confusional state, creatinine renal clearance decreased, dehydration. Orocal dosage: 1.25 G, Qd. During the same period patient was treated with KARDEGIC (1 Df, Qd) (View Kardegic Review and Kardegic Label ), IRBESARTAN (1 Df, Qd) (View Irbesartan Review and Irbesartan Label ), STILNOX /FRA/ (10 Mg, Unk) (View Stilnox /fra/ Review and Stilnox /fra/ Label ), VICTAN (1 Mg, Qd) (View Victan Review and Victan Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5256176-X | Anaemia, Blood Calcium Decreased, Blood Creatine Phosphokinase Increased, Blood Creatinine Increased, Blood Potassium Decreased, Carbon Dioxide Decreased, Confusional State, Creatinine Renal Clearance Decreased, Dehydration
Patient was taking Orocal (View Usage). After Orocal was administered, patient had the following side effects: anaemia, blood calcium decreased, blood creatine phosphokinase increased, blood creatinine increased, blood potassium decreased, carbon dioxide decreased, confusional state, creatinine renal clearance decreased, dehydration on Feb 26, 2007 from FRANCE Additional patient health information: Female patient , 80 years of age, weighting 99.21 lb, was diagnosed with essential hypertension and. Orocal dosage: 1.25 G, Qd. During the same period patient was treated with KARDEGIC (1 Df, Qd) (View Kardegic Review and Kardegic Label ), IRBESARTAN (1 Df, Qd) (View Irbesartan Review and Irbesartan Label ), STILNOX /FRA/ (10 Mg, Unk) (View Stilnox /fra/ Review and Stilnox /fra/ Label ), VICTAN (1 Mg, Qd) (View Victan Review and Victan Label ), VOLTAREN (View Voltaren Review and Voltaren Label ). Patient was hospitalized.

5122019-8 | Diarrhoea, Renal Failure Acute, Vomiting
Adverse event was reported on May 18, 2006 by a Female patient taking Orocal (View Usage) (Dosage: ) . Location: FRANCE , 73 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: diarrhoea, renal failure acute, vomiting. During the same period patient was treated with LEXOMIL (View Lexomil Review and Lexomil Label ), ATHYMIL (View Athymil Review and Athymil Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), SOLUPRED (View Solupred Review and Solupred Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), ZOCOR (View Zocor Review and Zocor Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.

5027139-4 | Arthralgia, Ear Pain, Erythema, Myalgia, Pharyngolaryngeal Pain, Pruritus, Pyrexia
on May 15, 2006 Female patient from FRANCE , weighting 127.9 lb, was diagnosed with bile duct cancer and was treated with Orocal (View Usage). Patient had the following side effects: arthralgia, ear pain, erythema, myalgia, pharyngolaryngeal pain, pruritus, pyrexia. Orocal dosage: 500 Mg. During the same period patient was treated with LAROXYL (3 Unit) (View Laroxyl Review and Laroxyl Label ), ZOPHREN (Unk) (View Zophren Review and Zophren Label ), GEMZAR (Unk) (View Gemzar Review and Gemzar Label ), IMOVANE (7.5 Mg) (View Imovane Review and Imovane Label ), ELOXATIN (View Eloxatin Review and Eloxatin Label ), VALIUM (25 Mg) (View Valium Review and Valium Label ), FORLAX (2 Unit) (View Forlax Review and Forlax Label ), MOPRAL (1 Unit) (View Mopral Review and Mopral Label ). Patient was hospitalized.

5011861-X | Diarrhoea, Renal Failure Acute
on May 18, 2006 Female patient from FRANCE , 73 years of age, weighting 110.2 lb, was treated with Orocal (View Usage). After Orocal was administered, patient had the following side effects: diarrhoea, renal failure acute. Orocal dosage: . During the same period patient was treated with LEXOMIL (View Lexomil Review and Lexomil Label ), ATHYMIL (View Athymil Review and Athymil Label ), KALEORID (View Kaleorid Review and Kaleorid Label ), MOPRAL (View Mopral Review and Mopral Label ), SOLUPRED (View Solupred Review and Solupred Label ), CARDENSIEL (View Cardensiel Review and Cardensiel Label ), ZOCOR (View Zocor Review and Zocor Label ), DOXYCYCLINE (View Doxycycline Review and Doxycycline Label ). Patient was hospitalized.